Cargando…

Age-Specific Effectiveness of an Oil-in-Water Adjuvanted Pandemic (H1N1) 2009 Vaccine Against Confirmed Infection in High Risk Groups in England

Background. The use of a squalene-containing (AS03) pandemic vaccine for high-risk groups in England allowed vaccine effectiveness (VE) of such novel oil-in-water adjuvanted vaccine to be evaluated. Methods. Cases of laboratory-confirmed pandemic (H1N1)2009 influenza in England between November 2009...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrews, Nick, Waight, Pauline, Yung, Chee-Fu, Miller, Elizabeth
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2011
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086445/ https://www.ncbi.nlm.nih.gov/pubmed/21148494 http://dx.doi.org/10.1093/infdis/jiq014

Ejemplares similares

Comparing the Immunogenicity of AS03-Adjuvanted 2009 Pandemic H1N1 Vaccine with Clinical Protection in Priority Risk Groups in England
por: Yung, Chee-Fu, et al.
Publicado: (2013)

Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation
por: Baguelin, Marc, et al.
Publicado: (2011)

Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England
por: Winstone, Anne Marie, et al.
Publicado: (2014)

Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A Streptococcus (GAS) Infection in England
por: Sinnathamby, Mary A, et al.
Publicado: (2023)

Statin Treatment and Mortality: Propensity Score-Matched Analyses of 2007–2008 and 2009–2010 Laboratory-Confirmed Influenza Hospitalizations
por: Laidler, Matthew R., et al.
Publicado: (2015)

Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis
por: Venkatesan, Sudhir, et al.
Publicado: (2017)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
por: Ladhani, Shamez N., et al.
Publicado: (2013)

Using the Indirect Cohort Design to Estimate the Effectiveness of the Seven Valent Pneumococcal Conjugate Vaccine in England and Wales
por: Andrews, Nick, et al.
Publicado: (2011)

7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement?
por: Choi, Yoon Hong, et al.
Publicado: (2011)

Effect of Pneumococcal Conjugate Vaccination on Serotype-Specific Carriage and Invasive Disease in England: A Cross-Sectional Study
por: Flasche, Stefan, et al.
Publicado: (2011)

CD4(+) T-Cell Expansion Predicts Neutralizing Antibody Responses to Monovalent, Inactivated 2009 Pandemic Influenza A(H1N1) Virus Subtype H1N1 Vaccine
por: Nayak, Jennifer L., et al.
Publicado: (2013)

Dysregulated T-Helper Type 1 (Th1):Th2 Cytokine Profile and Poor Immune Response in Pregnant Ferrets Infected With 2009 Pandemic Influenza A(H1N1) Virus
por: Yoon, Sun-Woo, et al.
Publicado: (2018)

Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine Among Pregnant Women: Lowered Antibody Response by Prior Seasonal Vaccination
por: Ohfuji, Satoko, et al.
Publicado: (2011)

Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England
por: Southern, Jo, et al.
Publicado: (2018)

Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England()
por: Field, Nigel, et al.
Publicado: (2014)

Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial
por: Nolan, Terry, et al.
Publicado: (2014)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010
por: Calatayud, Laurence, et al.
Publicado: (2011)

Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England
por: Clifford, Samuel, et al.
Publicado: (2023)

Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009–2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients
por: Muthuri, Stella G., et al.
Publicado: (2013)

Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England
por: Grint, Daniel J, et al.
Publicado: (2021)

Validation of Self-swab for Virologic Confirmation of Influenza Virus Infections in a Community Setting
por: Ip, Dennis K. M., et al.
Publicado: (2012)

The long road of pandemic vaccine development to rollout: A systematic review on the lessons learnt from the 2009 H1N1 influenza pandemic
por: Ankomah, Alex Asamoah, et al.
Publicado: (2022)

Treatment and Outcome of Culture-Confirmed Mycobacterium marinum Disease
por: Hendrikx, Louise, et al.
Publicado: (2022)

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant
por: Langley, Joanne M., et al.
Publicado: (2017)

Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial
por: Schuind, Anne, et al.
Publicado: (2015)

Mortality Attributable to Influenza in England and Wales Prior to, during and after the 2009 Pandemic
por: Green, Helen K., et al.
Publicado: (2013)

Risk factors associated with mortality in hospitalized patients with laboratory confirmed SARS-CoV-2 infection during the period of omicron (B.1.1.529) variant predominance
por: O'Leary, Ashley L., et al.
Publicado: (2023)

Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study
por: Stowe, Julia, et al.
Publicado: (2020)

Heterologous Prime-Boost Vaccination Using an AS03(B)-Adjuvanted Influenza A(H5N1) Vaccine in Infants and Children <3 Years of Age
por: Nolan, Terry, et al.
Publicado: (2014)

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study
por: Berkowitz, Elchonon M., et al.
Publicado: (2015)

Chikungunya Outbreak in Kedougou, Southeastern Senegal in 2009–2010
por: Sow, Abdourahmane, et al.
Publicado: (2017)

Variation in Tularemia Clinical Manifestations—Arkansas, 2009–2013
por: Lester Rothfeldt, Laura K., et al.
Publicado: (2017)

Rapid Immunization Against H5N1: A Randomized Trial Evaluating Homologous and Cross-Reactive Immune Responses to AS03(A)-Adjuvanted Vaccination in Adults
por: Lasko, Benjamin, et al.
Publicado: (2011)

Mumps Complications and Effects of Mumps Vaccination, England and Wales, 2002–2006
por: Yung, Chee-Fu, et al.
Publicado: (2011)

Declining Genital Warts in Young Women in England Associated With HPV 16/18 Vaccination: An Ecological Study
por: Howell-Jones, Rebecca, et al.
Publicado: (2013)

Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis
por: Kamelian, Kimia, et al.
Publicado: (2019)

Congenital syphilis in Brazil: distribution of cases notified from 2009 to 2016
por: Rêgo, Adriana Sousa, et al.
Publicado: (2020)

Influenza Infection and Risk of Acute Myocardial Infarction in England and Wales: A CALIBER Self-Controlled Case Series Study
por: Warren-Gash, Charlotte, et al.
Publicado: (2012)

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant
por: Chen, Wilbur H., et al.
Publicado: (2014)

A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults
por: Baber, James, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_30qmia9mn2nfg12edo9dhla2cd